Quercetin attenuates cisplatin-induced mitochondrial apoptosis via PI3K/Akt mediated inhibition of oxidative stress in pericytes and improves the blood labyrinth …
TL Huang, WJ Jiang, Z Zhou, TF Shi, M Yu, M Yu… - Chemico-Biological …, 2024 - Elsevier
Cisplatin (CDDP) is broadly employed to treat different cancers, whereas there are no drugs
approved by the Food and Drug Administration (FDA) for preventing its side effects …
approved by the Food and Drug Administration (FDA) for preventing its side effects …
Quercetin attenuates cisplatin-induced mitochondrial apoptosis via PI3K/Akt mediated inhibition of oxidative stress in pericytes and improves the blood labyrinth …
TL Huang, WJ Jiang, Z Zhou, TF Shi… - Chemico-Biological …, 2024 - ui.adsabs.harvard.edu
Cisplatin (CDDP) is broadly employed to treat different cancers, whereas there are no drugs
approved by the Food and Drug Administration (FDA) for preventing its side effects …
approved by the Food and Drug Administration (FDA) for preventing its side effects …
Quercetin attenuates cisplatin-induced mitochondrial apoptosis via PI3K/Akt mediated inhibition of oxidative stress in pericytes and improves the blood labyrinth …
TL Huang, WJ Jiang, Z Zhou, TF Shi… - Chemico …, 2024 - pubmed.ncbi.nlm.nih.gov
Cisplatin (CDDP) is broadly employed to treat different cancers, whereas there are no drugs
approved by the Food and Drug Administration (FDA) for preventing its side effects …
approved by the Food and Drug Administration (FDA) for preventing its side effects …
Quercetin attenuates cisplatin-induced mitochondrial apoptosis via PI3K/Akt mediated inhibition of oxidative stress in pericytes and improves the blood labyrinth …
TL Huang, WJ Jiang, Z Zhou, TF Shi, M Yu… - Chemico-biological …, 2024 - europepmc.org
Cisplatin (CDDP) is broadly employed to treat different cancers, whereas there are no drugs
approved by the Food and Drug Administration (FDA) for preventing its side effects …
approved by the Food and Drug Administration (FDA) for preventing its side effects …